Harbin Gloria Pharmaceuticals (002437): The product pipeline is rich, and performance is gradually recovering.

Summary report: Harbin Gloria Pharmaceuticals is a biopharmaceutical company with a product pipeline covering cardiovascular drugs, orthopedic drugs, Vitamins, electrolyte drugs, and other fields. Currently, the company has products such as An Nao Wan/tablets, deer gourd polypeptide injection, and multivitamin injection.

TianfengDec 29, 2024 20:57

Express News | Tianfeng Securities Co., Ltd. has given Harbin Gloria Pharmaceuticals Co., Ltd. an initial rating of 'buy'.

BreakingsDec 29, 2024 20:28

Harbin Gloria Pharmaceuticals (002437.SZ): Has not yet repurchased company shares.

Gelonghui December 2丨Harbin Gloria Pharmaceuticals (002437.SZ) announced that as of November 30, 2024, the company has not yet repurchased its shares through the dedicated securities account for repurchase.

Gelonghui FinanceDec 2, 2024 21:13

Harbin Gloria Pharmaceuticals (002437.SZ): Director Wang Dongxu has completed the shareholding of 0.21 million shares.

On December 2, Gelonghui reported that harbin gloria pharmaceuticals (002437.SZ) announced that on December 2, 2024, the company received a "Shareholding Plan Progress Notification Letter" issued by director Wang Dongxu. Mr. Wang's shareholding plan has been fully implemented; he has reduced his holdings by 0.21 million shares, accounting for 0.0092% of the total.

Gelonghui FinanceDec 2, 2024 21:12

Express News | This week, more than 20 listed companies disclosed the repurchase and shareholding related information. Pingdingshan Tianan Coal Mining plans to repurchase special loans not exceeding 0.7 billion yuan.

BreakingsNov 2, 2024 13:45

Express News | Harbin Gloria Pharmaceuticals: Received the "Loan Commitment Letter" and obtained special financing support for repurchasing company shares.

BreakingsOct 31, 2024 19:43